SPECIAL NOTICE
A -- Intent to Award Sole Source - Joint Warfighter Medical Research Program (JWMRP)
- Notice Date
- 4/8/2016
- Notice Type
- Special Notice
- NAICS
- 541711
— Research and Development in Biotechnology
- Contracting Office
- Department of the Army, U.S. Army Medical Research Acquisition Activity, U.S. Army Medical Research Acquisition Activity, Attn: MCMR-AAA, 820 Chandler Street, Frederick, MD 21702-5014, Maryland, 21702-5014, United States
- ZIP Code
- 21702-5014
- Solicitation Number
- W81XWH-15-JWMR
- Archive Date
- 5/7/2016
- Point of Contact
- Douglas A. Medcalf, Phone: 3016192394
- E-Mail Address
-
douglas.a.medcalf.civ@mail.mil
(douglas.a.medcalf.civ@mail.mil)
- Small Business Set-Aside
- N/A
- Description
- Intent to Award Sole Source Joint Warfighter Medical Research Program (JWMRP) The United States Army Medical Research Acquisitions Activity (USAMRAA), on behalf of the U.S. Army Medical Material Development Activity (USAMMDA), is issuing this notice of Intent to Award a Sole Source contract. This is not a request for proposals. This notice does not represent a commitment by the government to pay for costs incurred from the preparation and/or submission of data in response to this notice. This is a notice of the intent to award a sole source contract to The University of Texas Health Science Center at Houston, in accordance with FAR 6.302-1(a)(2), only one responsible source and no other supplies or services will satisfy agency requirements. This project is a continuation of a grant titled "Treatment of Adult Severe Traumatic Brain Injury Using Autologous Bone Marrow Mononuclear Cells". The work addresses the conduct of a stand-alone, adequately powered prospective, randomized, blinded, placebo controlled, Phase 2 clinical study to determine if the intravenous infusion of Bone Marrow Mononuclear Cells (BMMC) after severe Traumatic Brain Injury (TBI) (post resuscitation Glasgow Coma Score (GCS) 3-8) in adults is safe and results in improvement of outcomes. As directed by Congress in the Department of Defense Appropriations Bill, 2014 Report 113-473, page 282-283, $45M "shall be used to augment and accelerate high priority Department of Defense (DoD) and Service medical requirements and to continue prior year initiatives that are close to achieving their objectives and yielding a benefit to military medicine. The funds shall not be used for new projects or for basic research." For this reason, it was determined that the cited statutory authority permitting other than full and open competition is supported and required. This Bill essentially limits the competition to contractors that have existing Congressional Special Interest Research Projects (contracts or assistance agreements) and have a military relevance. The Bill also states that funds shall be awarded at the discretion of the Secretary of Defense following a review of medical research and development gaps. The strategy in executing the JWMRP was to find highly valued research efforts on a research grant or contract that could meet critical service requirements and that were not being continued through other appropriations. This notice is provided solely as information to the marketplace. CONTACT INFORMATION: Questions may be submitted to Mr. Doug Medcalf at douglas.a.medcalf.civ@mail.mil no later than the close of business 22 April 2016.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/USA/USAMRAA/DAMD17/W81XWH-15-JWMR/listing.html)
- Record
- SN04078857-W 20160410/160408234917-0422265b77b10782b61c311680679a71 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |